Axon Capital’s Baker Hughes BKR Stock Holding History

Axon Capital’s Portfolio BKR Stock Details BKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-172,400	Closed	-$7.85M	–	16
2025 Q4	$7.85M	Buy	+172,400	New	+$8.18M	6.72%	6

Other funds holding BKR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Axon Capital's BKR Position: Q1 2026 in Review

Axon Capital sold out of Baker Hughes (BKR) in Q1 2026, closing a stake of 172,400 shares — an estimated $7.85M sold.

Axon Capital first reported a position in BKR in Q4 2025 and held it in 1 quarter. The position peaked at $7.85M in Q4 2025. 1,149 funds tracked by Wall St. Rank hold BKR as of Q1 2026.

Axon Capital reported no remaining Baker Hughes position as of Q1 2026 after selling out during the quarter.
Axon Capital sold 172,400 Baker Hughes shares in Q1 2026, an estimated $7.85M.
Axon Capital first reported a position in Baker Hughes in Q4 2025 and held it in 1 quarter.
Axon Capital's Baker Hughes position peaked at $7.85M in Q4 2025.
1,149 funds tracked by Wall St. Rank held Baker Hughes as of Q1 2026.

Based on Axon Capital's 13F filing for Q1 2026, filed 15 May 2026.